GNTA GNTA
Company Profile ↓Company Overview
GNTA (GNTA) is a publicly traded company listed on with a market capitalization of $31.16M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.35.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -65.00% |
| 6 Months: | +50.45% |
| 3 Months: | +98.51% |
| 1 Month: | -17.39% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- Golden Cross9d ago
- RSI (14)42.60 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 78.5% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 11.04M | 11.73M | 9.76M | 6.60M |
| Operating Income | - | -11.04M | -11.73M | -9.76M | -6.60M |
| EBITDA | - | -11.04M | -11.69M | -9.72M | -6.58M |
| Interest Expense | 11.72K | - | - | - | - |
| Pretax Income | - | -8.48M | -11.65M | -8.91M | -6.53M |
| Tax Provision | - | 0 | 0 | 0 | 0 |
| Net Income | - | -8.48M | -11.65M | -8.91M | -6.53M |
| Diluted EPS | - | -0.47 | -0.64 | -0.49 | -0.33 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 33.44M | 22.35M | 14.82M | 31.89M |
| Current Assets | - | 31.72M | 21.26M | 14.47M | 29.98M |
| Cash & Equivalents | - | 29.79M | 3.69M | 4.58M | 5.53M |
| Inventory | - | - | - | - | - |
| Receivables | - | 1.56M | 2.00M | 1.45M | 1.29M |
| Total Liabilities | - | 2.30M | 1.91M | 2.33M | 10.05M |
| Current Liabilities | - | 2.18M | 1.74M | 2.10M | 2.12M |
| Long Term Debt | - | - | - | - | 7.60M |
| Total Debt | - | - | - | - | 7.60M |
| Total Equity | - | 31.14M | 20.43M | 12.50M | 21.84M |
| Shares Outstanding | - | 18.22M | 18.22M | 18.29M | 23.43M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -7.42M | -11.21M | -6.24M | -6.87M |
| Investing Cash Flow | - | -27.07K | -14.89M | 6.88M | -14.54M |
| Financing Cash Flow | - | 0 | 531 | 270.88K | 22.29M |
| Capital Expenditure | - | -27.07K | -13.79K | -4.47K | -7.62K |
| Free Cash Flow | - | -7.45M | -11.22M | -6.24M | -6.88M |
| Net Change in Cash | - | -7.45M | -26.10M | 913.77K | 875.56K |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | - | - | - | - |
| ROE % | - | -27.2% | -57.0% | -71.3% | -29.9% |
| ROCE % | - | -35.3% | -56.9% | -76.7% | -22.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for GNTA
Genenta Science (GNTA) backs capital and reverse split plans - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNYjFTM2tranFJNEh3ckloVkdYV3VoTUFrRm8zWTRFX0F6aUk4ekd0b0pQUVFhZzBwRExYR0tuUTNvQ0MwTm5WeUhsS2lmY19QSkNMVmpWSUVUdExOYS1SOTJYRjRodk13aWI3akd1OXBEZUVmV081azBjOTdmY2w4bmxvcWtVY2x1ZVJ5ek…
Genenta Science Shareholders Approve Major Capital Authorization and Reverse Split Plan - theglobeandmail.com
<a href="https://news.google.com/rss/articles/CBMihAJBVV95cUxPTVlzcm11UnZzNG5UNHA5TDRvM01GZy1WN0RlRmthWE5EcFhjelVtZG11akFydEU5b0prek9RZ2E5MzZ6Uzk1aUxXLVpjcngwOGxWSnMwcnFydFNIV0g0WnVuZGVPTnJ3TFFHd1FmclpDY1gyRFM5Z0Zib25MRDMxRDA5ZWJwZHRIZjZaaz…
GNTA Stock Explodes On Volume As Traders Scan Biotech Charts - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMifEFVX3lxTE1aQWlNYUVSZVo3Zll3STA3LThlR1ppSnl1U3ZIclRrVEFSOUQtTnhVWEdEbGlRbS1zejFBX0VWT2lvTGJjOS0yYWV6MGxLa1JjeUdvNFJFMkVZbmhWaGlDWE5YZUc5V1A1VWN6bF9lR2xFa25OQU5nZV8tdlI?oc=5" target="_blank">…
GNTA Stock Sees Volatile Spike As Traders Eye Key Levels - timothysykes.com
<a href="https://news.google.com/rss/articles/CBMie0FVX3lxTE1wQ0VxSUZxNy14Z1BmMlJUVEl2VUMwUHhvS041QkRDQVNPenBidXlkVmxLTjAzamZ4UWpfQWpieTFLV3FpeWdMX2N3bnNBSTdJd3ZTMU9KdjNpQktoeHVQMUUyeWdxaUF2NFlpaWNKUDZabTVJVUkxTHdTYw?oc=5" target="_blank">G…
Genenta Science SPA (GNTA) Shifting from Biotech to Defense Business - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxQaUJfcTdWRC1BYU5iUW5SSXM4cENlak1JLTBERDhfeUtsNVpaOVluS0VqTnFJWkwyTnhkVUJ5ZnVtTjRPcTB0YnhzWlVHUHF6eUcwa1VVVTlwOEZwQ3U2WndDdHJXR3dLN0xxbTJVR294akF2R0xyV2hXUEYzckRlNy1VRW41dw?oc=5" t…
Robot Tackles Maintenance Inside a Fusion Machine at 20M°C - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxPV2lVREpaTUpJVXlhZ2xOWVk3TFdpbk9lSDZnclN6d3c0anluZlM5LTJDbW80d0RlTlg3U29TYkUxSndPVENNMXdhNTk1NW1oX1ZzZ1BRNlByalpfeWlNVEFqZF9Uamo0WHJ2UmZBbTRJS2FzT1FKcWVpbTBRR2NiUTBzTTdZV3p3b2JSZF…
GNTA — Frequently Asked Questions
What is the current share price of GNTA?
As of 2026-08-05 17:25 PDT, GNTA trades at $1.33 on NASDAQ/NYSE. Its 52-week range is $0.58 to $6.20.
What is the market capitalisation of GNTA?
GNTA has a market capitalisation of $31.16M on NASDAQ/NYSE.
What is the P/E ratio of GNTA?
GNTA trades at a trailing price-to-earnings (P/E) ratio of -4.03. Its price-to-book (P/B) ratio is 1.43.
What is the return on equity (ROE) of GNTA?
GNTA has a return on equity (ROE) of -29.90%. Its return on capital employed (ROCE) is -22.18%.
Is GNTA a good stock to buy?
This page provides a data-driven analysis of GNTA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.